Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
about
Role of Tim-3 in hepatitis B virus infection: An overviewInflammatory status in human hepatic cirrhosisTim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionLiver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice.The role of T cell immunoglobulin and mucin domain-3 in immune thrombocytopenia.Immunotherapeutic approaches for hepatocellular carcinomaRegulation of T cell responses by the receptor molecule Tim-3.Targeting regulatory T cells to improve vaccine immunogenicity in early life.Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.Tim-3 expression defines regulatory T cells in human tumors.Cis association of galectin-9 with Tim-3 differentially regulates IL-12/IL-23 expressions in monocytes via TLR signalingSoluble costimulatory molecule sTim3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion.Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii.Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity.CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.Polymorphisms in TIM-3 and breast cancer susceptibility in Chinese women: A case-control study.Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection.Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.Modulating T regulatory cells in cancer: how close are we?Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV-Infected Individuals.Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors.Protection of CD4+ T cells from hepatitis C virus infection-associated senescence via ΔNp63-miR-181a-Sirt1 pathway.Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development.Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression.Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6.KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.Induction, control, and plasticity of Treg cells: the immune regulatory network revised?
P2860
Q26768530-004FDC91-FB63-438A-864A-B2CA93A341FCQ26778040-56F9B328-22DD-45E6-A1A3-722FF59B48FAQ28506567-F1670EB2-0DF0-4126-936D-EDBEE8FF9F85Q30409150-F838AEE0-C044-434A-A9BD-780F34CFE32BQ33412416-A727A5B7-A261-4E45-A1B1-4D271D8B20B5Q33779723-0C86C533-BBFD-4DFD-863A-020AE2438A2CQ34017074-646045FD-7F60-45EA-8B32-E4BEA92C82C0Q34164169-EE0B3789-8901-4772-BB93-4094F3AC35B0Q34195216-B420E097-DFF8-481D-99AC-4618BE127B17Q34634058-24BCBD7B-457F-4594-AB00-DEBF21610F19Q34965205-142FCF0E-5F17-4E8E-A9EB-B579FB8D5FD1Q35958659-A71D12AA-4147-4C27-B739-458BB8027E0CQ36760150-F0F87F83-680E-4BF9-9AB5-48A34CE8C637Q36845835-7C864ED4-FED7-4FE8-A44C-1BBDD2C40F2EQ37252732-991B9109-1EA6-4E14-B4F0-704A14465628Q37320024-3BD4CA55-39E7-46B0-B888-48C63E4C83A9Q37374059-0B64F7A0-4C51-4494-889F-1EF6AD579DE4Q37495787-077A6BC8-4D62-416A-82D5-AE237E6099AFQ37536685-63518132-E577-4617-ADF1-FAAC5B18F3C8Q37593573-A358FDAA-3103-4193-B56C-25DC59D42B00Q37723456-98DE1153-F794-4457-A0B3-39B1F2FBDA5CQ38080732-2375444D-23DE-402C-88AD-99E459730177Q38097311-88B3216F-87B7-4346-AA5F-B37400674A6CQ38206528-0DF1F29A-1AE5-4F16-968C-630F0686EE1BQ38223279-381CED3C-0775-4D1E-A13F-3BF0D34C0BB4Q38728953-B51DC1A2-16DD-4418-B0C5-C1A63BC5A947Q38835601-4572FAE6-08C3-4E06-BA8E-6C59DB6E3B8AQ38899741-E93E54C3-EE5D-4926-BB0D-F67C34CCD0A7Q39044628-33507A3A-46FF-428E-BF22-4DDF45AE1CCEQ39601470-405CF595-7E2D-4A60-91EE-725384EABE27Q40473718-668722CF-83DC-46F0-BBCB-4831213F69E9Q40475655-B3714D36-5FFE-4366-B85F-27C2A48D7E8FQ40686250-991C101B-EBA3-4D68-BA59-4F7DE446DCE1Q40745016-01705712-DF16-4D3D-BA29-F3778F5747C7Q41198488-DB87422B-6CEF-4729-9FB2-CC2AA2D24B07Q41201828-9CAEE031-150A-4D42-923D-DB00E6C52E2FQ41616036-F2DBA9C8-F2A2-4A2B-88E0-3BF3588BF4ABQ41877181-6EA4C9FF-9873-45BF-955F-1FE9CD1C791BQ41894013-EA4086A3-9FF1-43E2-8E85-C019C97E1D45Q44661076-51E4F649-1228-425D-B910-7EA9B1B66448
P2860
Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@en
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@nl
type
label
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@en
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@nl
prefLabel
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@en
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@nl
P2093
P2860
P356
P1476
Tim-3 pathway controls regulat ...... g hepatitis C virus infection.
@en
P2093
Cheng J Ma
Jia M Wang
Jonathan P Moorman
Ying Zhang
Zhan S Jia
P2860
P304
P356
10.4049/JIMMUNOL.1200162
P407
P577
2012-06-15T00:00:00Z